摘要
免疫力是一个平衡的地位,具有足够的生物防御能力来承认和打击“非自我”,以及承认“自我”的充分宽容。为了维持这种免疫稳态,需要组织良好的T细胞免疫网络,其部分取决于替代效应T细胞的良好控制的发展,具有不同的细胞因子谱系。最近的研究指出,发展胎儿T细胞网络是早期生活中不良因素的非常敏感的毒理学靶位。流行病学和实验研究显示,T细胞发育毒性与成人免疫疾病之间存在着密切的关系。考虑到炎症和免疫疾病已成为全球日益增长的健康问题,现在越来越多地关注T细胞的发育毒性。我们提出,不利因素可能对早期生命中免疫系统的关键功能有编程效应,这对于胎儿T细胞发育和不同T细胞谱系平衡的建立至关重要。永久性干扰的胸腺内或外周T细胞发育可能反过来导致后期生活中的免疫疾病。在本手稿中,我们回顾了免疫功能障碍和免疫疾病后期的不利因素如何影响早期生命的T细胞发育,进一步阐明了机制。这些机制将有助于通过干扰这些途径预防和治疗免疫疾病流行率的增加。
关键词: 免疫毒理学,生殖毒性,T细胞,胸腺细胞,胸腺,免疫疾病。
图形摘要
Current Drug Targets
Title:Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases
Volume: 18 Issue: 10
关键词: 免疫毒理学,生殖毒性,T细胞,胸腺细胞,胸腺,免疫疾病。
摘要: Immunity is a balanced status with adequate biological defenses to recognize and fight “non-self”, as well as adequate tolerance to recognize “self”. To maintain this immune homeostasis, a well-organized T cell immune network is required, which in part depends on the well-controlled development of alternative effector T cells, with different cytokine repertoires. Recent researches have pointed that developing fetal T cells network is a remarkably sensitive toxicological target for adverse factors in early life. Epidemiological and experimental studies showed an inseparable relationship between T cell developmental toxicity and immune diseases in adults. Considering that the inflammatory and immune disorders have become a growing health problem worldwide, increasing attention is now being paid to the T cell developmental toxicity. We propose that adverse factors may have programming effects on the crucial functions of immune system during early life which is critical for fetal T cell development and the establishment of the distinct T cell repertoires balance. The permanently disturbed intrathymic or peripheral T cell development may in turn lead to the immune disorders in later life. In this manuscript, we reviewed how adverse factors affected T cell development in early-life with the consequence of the immune dysfunction and immune diseases, and further elucidate the mechanisms. These mechanisms will be helpful in prevention and treatment of the increased prevalence of immune diseases by interfering those pathways.
Export Options
About this article
Cite this article as:
Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases, Current Drug Targets 2017; 18 (10) . https://dx.doi.org/10.2174/1389450117666161124145641
DOI https://dx.doi.org/10.2174/1389450117666161124145641 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Current Drug Targets Microbubbles as Drug Delivery Systems in Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula
Current Bioinformatics Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Comprehensive Analysis of Key Proteins Involved in Radioresistance of Prostate Cancer by Integrating Protein-protein Interaction Networks
Current Bioinformatics The Non-ABC Drug Transporter RLIP76 (RALBP-1) Plays a Major Role in the Mechanisms of Drug Resistance
Current Drug Metabolism Human Carbonyl Reductases
Current Drug Metabolism BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets Novel Mitochondria-targeted Drugs for Cancer Therapy
Mini-Reviews in Medicinal Chemistry Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Current Cancer Therapy Reviews Biomaterial and Mesenchymal Stem Cell for Articular Cartilage Reconstruction
Current Stem Cell Research & Therapy Relevant Physicochemical Descriptors of “Soft Nanomedicines” to Bypass Biological Barriers
Current Pharmaceutical Design Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Nicotine, Body Weight and Potential Implications in the Treatment of Obesity
Current Topics in Medicinal Chemistry Development of RNA Aptamer-Based Therapeutic Agents
Current Medicinal Chemistry Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
Reviews on Recent Clinical Trials Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology